Cibotercept
Cibotercept (KER-012) is a novel, modified, investigational activin receptor type IIB (ActRIIB) ligand trap designed to target select TGF-β ligands, including activins A and B, GDFs 8 and 11, to rebalance the defective activin receptor type II signaling observed in PAH[1][2].
Product Specifications
CAS Number
2769700-97-0
Product Name Alternative
KER-012
UNSPSC
12352203
Target
TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cibotercept.html
Purity
99.85
References & Citations
[1]Cibotercept|[2]Sebastien J. Sannajust, et al. Nonclinical Assessment of Cibotercept (KER-012), A Novel Modified ActRIIB Ligand Trap, For the Treatment of Pulmonary Arterial Hypertension.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV686290 1.0 µg DNA
PCYOX1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 
IDO1-7325HAF488 20 μg- 50 μg- 100 μg
Recombinant Human IDO1 Protein, Gly/Pro-tagged, Alexa Fluor 488 conjugated
Sign In for Pricing
View Details 
QP7709-ec-100ug 100ug
Recombinant Mouse F-box/ WD repeat-containing protein 10 Protein, His-SUMO, E.coli-100ug
Sign In for Pricing
View Details